These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6110746)

  • 1. Age-dependent differences in the effect of phenprocoumon on the vitamin K1-epoxide cycle in rats.
    Trenk D; Beermann D; Oesch F; Jähnchen E
    J Pharm Pharmacol; 1980 Dec; 32(12):828-32. PubMed ID: 6110746
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of the enantiomers of phenprocoumon and warfarin on the vitamin K1-epoxide/vitamin K1 ratio in rat plasma.
    Schmidt W; Beermann D; Oesch F; Jähnchen E
    J Pharm Pharmacol; 1979 Jul; 31(7):490-1. PubMed ID: 38329
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic interconversion of vitamin K1 and vitamin K1 2,3-epoxide in man.
    Bechtold H; Trenk D; Meinertz T; Rowland M; Jähnchen E
    Br J Clin Pharmacol; 1983 Dec; 16(6):683-9. PubMed ID: 6661354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
    Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coumarins and the vitamin K-K epoxide cycle. Lack of resistance to coumatetralyl in warfarin-resistant rats.
    Bell RG; Caldwell PT; Holm EE
    Biochem Pharmacol; 1976 May; 25(9):1067-70. PubMed ID: 1267852
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of prothrombin synthesis and epoxidation of vitamin K1 by anticoagulants in vitro.
    Bell RG; Stark P
    Biochem Biophys Res Commun; 1976 Sep; 72(2):619-25. PubMed ID: 985502
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K1 metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats.
    Leck JB; Park BK
    Biochem Pharmacol; 1981 Jan; 30(2):123-8. PubMed ID: 7236301
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone.
    Preusch PC; Suttie JW
    Biochim Biophys Acta; 1984 Mar; 798(1):141-3. PubMed ID: 6704420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the interactions of phenprocoumon with chlordiazepoxide in rats (author's transl)].
    Kinawi A; Baumgartl I
    J Clin Chem Clin Biochem; 1977 Aug; 15(8):425-9. PubMed ID: 915441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
    Spahn H; Kirch W; Mutschler E; Ohnhaus EE; Kitteringham NR; Lögering HJ; Paar D
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):97S-102S. PubMed ID: 6743480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of acitretin on the hypothrombinemic action of phenprocoumon in healthy volunteers.
    Hartmann D; Mosberg H; Weber W
    Dermatologica; 1989; 178(1):33-6. PubMed ID: 2521833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of cimetidine on action of phenprocoumon.
    Harenberg J; Zimmermann R; Staiger C; de Vries JX; Walter E; Weber E
    Eur J Clin Pharmacol; 1982 Oct; 23(4):365-7. PubMed ID: 7173307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.
    Schmidt W; Jähnchen E
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):643-63. PubMed ID: 529027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of interaction between ofloxacin and phenprocoumon.
    Verho M; Malerczyk V; Rosenkranz B; Grötsch H
    Curr Med Res Opin; 1987; 10(7):474-9. PubMed ID: 3476252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W; Jähnchen E
    J Pharm Pharmacol; 1977 May; 29(5):266-71. PubMed ID: 17688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of coumarins. Significance of vitamin K epoxide.
    Sadowski JA; Suttie JW
    Biochemistry; 1974 Aug; 13(18):3696-9. PubMed ID: 4853124
    [No Abstract]   [Full Text] [Related]  

  • 19. Individual variation in the response to phenprocoumon.
    Husted S; Andreasen F
    Eur J Clin Pharmacol; 1977; 11(5):351-8. PubMed ID: 880974
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats.
    Trenk D; Winkelmann B; Jähnchen E; Oie S
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):1-12. PubMed ID: 3373415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.